UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S9-S10

2021

Volltextzugriff (PDF)

P031 Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study

The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S8-S8

2021

Volltextzugriff (PDF)

P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study

The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S9-S9

2021

Volltextzugriff (PDF)

S693 Impact of Prior Biologic Exposure on Patient Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S313-S314

2021

Volltextzugriff (PDF)

S867 Ozanimod for Moderate-to-Severe Ulcerative Colitis: Results From the North American Population During Induction and Maintenance in the Phase 3 True North Study

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S405-S405

2021

Volltextzugriff (PDF)

Calcitonin and calcitonin receptors: bone and beyond

International journal of experimental pathology, 2000-12, Vol.81 (6), p.405-422

Pondel, Marc

2000

Volltextzugriff (PDF)

Cost-efficiency and expanded access modeling of toripalimab versus pembrolizumab in locally advanced or metastatic nonsquamous non-small cell lung cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e20590-e20590

2024

Volltextzugriff (PDF)

Cost-efficiency and budget-neutral expanded access modeling of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma

Journal of medical economics, 2024, Vol.27 (sup3), p.1-8

2024

Volltextzugriff (PDF)

Cost-efficiency and budget-neutral expanded access modeling of pembrolizumab versus the novel PD-1 inhibitor toripalimab in locally advanced or metastatic nonsquamous non-small cell lung cancer

Journal of medical economics, 2024-04, Vol.27 (sup3), p.24-33

2024

Volltextzugriff (PDF)

Budget impact analysis of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma

Journal of medical economics, 2024-04, Vol.27 (sup3), p.9-23

2024

Volltextzugriff (PDF)

Patterns of localization and cytoskeletal association of two vegetally localized RNAs, Vg1 and Xcat-2

Development (Cambridge), 1995-01, Vol.121 (1), p.201-208

1995

Volltextzugriff (PDF)

Tu1464: EARLY MUCOSAL HEALING AT WEEK 10 WITH OZANIMOD PREDICTS CLINICAL OUTCOMES AT WEEK 52: POST HOC ANALYSIS OF THE PHASE 3 TRUE NORTH CLINICAL TRIAL

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-972

2022

Volltextzugriff (PDF)

Cloning and transcriptional analysis of the mouse receptor activity modifying protein-1 gene promoter

BMC molecular biology, 2005-03, Vol.6 (1), p.7-7

2005

Volltextzugriff (PDF)

Tu1472: RAPIDITY OF OZANIMOD-INDUCED SYMPTOMATIC RESPONSE AND REMISSION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE INDUCTION PERIOD OF TRUE NORTH

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-976

2022

Volltextzugriff (PDF)

Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells

Cancer cell international, 2003-04, Vol.3 (1), p.6-6, Article 6

2003

Volltextzugriff (PDF)

15: LONG-TERM CARDIAC SAFETY OF OZANIMOD IN PHASE 3 CLINICAL PROGRAM OF ULCERATIVE COLITIS AND RELAPSING MULTIPLE SCLEROSIS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-5-S-6

2022

Volltextzugriff (PDF)

Calcitonin, angiotensin II and FPP significantly modulate mouse sperm function

Molecular human reproduction, 2001-03, Vol.7 (3), p.245-253

2001

Volltextzugriff (PDF)

P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study

The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S9

2021

Volltextzugriff (PDF)

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S9

2021

Volltextzugriff (PDF)

P031 Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study

The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S8

2021

Volltextzugriff (PDF)

Localized Maternal mRNA Related to Transforming Growth Factor β mRNA is Concentrated in a Cytokeratin-Enriched Fraction from Xenopus Oocytes

Proceedings of the National Academy of Sciences - PNAS, 1988-10, Vol.85 (20), p.7612-7616

1988

Volltextzugriff (PDF)

The Xenopus oocyte cytoskeleton and its role in the localization of messenger-RNA

Pondel, Marc Dean

1989

Volltextzugriff (PDF)

During stepwise cue deletion, rat place behaviors correlate with place unit responses

Brain research, 1985-03, Vol.330 (2), p.369-372

1985

Volltextzugriff (PDF)

The effect of anticipated future interaction on reward allocation in same- and opposite-sex dyads

Journal of personality, 1981-12, Vol.49 (4), p.438-448

1981

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(23)
Dissertationen
(1)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

P031 Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study

P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study

S693 Impact of Prior Biologic Exposure on Patient Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study

S867 Ozanimod for Moderate-to-Severe Ulcerative Colitis: Results From the North American Population During Induction and Maintenance in the Phase 3 True North Study

Calcitonin and calcitonin receptors: bone and beyond

Cost-efficiency and expanded access modeling of toripalimab versus pembrolizumab in locally advanced or metastatic nonsquamous non-small cell lung cancer

Cost-efficiency and budget-neutral expanded access modeling of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma

Cost-efficiency and budget-neutral expanded access modeling of pembrolizumab versus the novel PD-1 inhibitor toripalimab in locally advanced or metastatic nonsquamous non-small cell lung cancer

Budget impact analysis of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma

Patterns of localization and cytoskeletal association of two vegetally localized RNAs, Vg1 and Xcat-2

Tu1464: EARLY MUCOSAL HEALING AT WEEK 10 WITH OZANIMOD PREDICTS CLINICAL OUTCOMES AT WEEK 52: POST HOC ANALYSIS OF THE PHASE 3 TRUE NORTH CLINICAL TRIAL

Cloning and transcriptional analysis of the mouse receptor activity modifying protein-1 gene promoter

Tu1472: RAPIDITY OF OZANIMOD-INDUCED SYMPTOMATIC RESPONSE AND REMISSION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE INDUCTION PERIOD OF TRUE NORTH

Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells

15: LONG-TERM CARDIAC SAFETY OF OZANIMOD IN PHASE 3 CLINICAL PROGRAM OF ULCERATIVE COLITIS AND RELAPSING MULTIPLE SCLEROSIS

Calcitonin, angiotensin II and FPP significantly modulate mouse sperm function

P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

P031 Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study

Localized Maternal mRNA Related to Transforming Growth Factor β mRNA is Concentrated in a Cytokeratin-Enriched Fraction from Xenopus Oocytes

The Xenopus oocyte cytoskeleton and its role in the localization of messenger-RNA

During stepwise cue deletion, rat place behaviors correlate with place unit responses

The effect of anticipated future interaction on reward allocation in same- and opposite-sex dyads

Suchergebnisse filtern